Thus, increased expression of glycolysis-related enzymes and Myc, as well as mutations in TP53, can generate more energy by increasing the level of glucose metabolism and are key factors affecting disease progression and poor prognosis in DLBCL. The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.